Drug Profile
Nilotinib companion diagnostic - MolecularMD/Novartis
Alternative Names: MRDx BCR-ABLLatest Information Update: 12 Sep 2019
Price :
$50
*
At a glance
- Originator Novartis
- Developer Genoptix; MolecularMD
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Chronic myeloid leukaemia